{"link": "http://hdl.handle.net/10138/157276", "subject": "l\u00e4\u00e4keainekemia', 'l\u00e4\u00e4keainekemia", "wordcount": 15213, "major": "Synthesis of betulin derivatives with new bioactivities", "abstract": "Betulin is a triterpene class natural product present, for example, in the outer layer of birch bark, which is a low-value waste product of the forestry industry in Northern Hemisphere. Oxidation products of betulin, namely betulinic acid and betulonic acid, have been shown to have several biological activities. This makes betulin an interesting starting point for drug discovery projects. \\n\\nIn this work, mainly ring A-fused heterocyclic derivatives of betulin were synthesized, and their structure-activity relationships against a protozoan parasite Leishmania donovani, prostate cancer cell lines, a serine hydrolase enzyme (ABHD12), and inflammatory factors were studied. The heterocycles used included pyridine, pyrazine, pyrazole, indole, isoxazole, and oxazole rings. Also, positions C-28 and C-20 of these compounds were modified and the resulting structure-activity relationships (SAR) were studied. \\n\\nAmong the tested compounds, two heterocyclic betulin derivatives showed significant inhibition against L. donovani amastigotes growth. These compounds showed improved activity compared to the heterocyclic betulin derivatives tested previously. Also, a betulinderived potent anti-HIV compound, bevirimat, showed L. donovani growth inhibition at a similar level to the ring A-fused heterocyclic betulin derivatives. However, further optimization is needed to get more potent betulin derivative activity against L. donovani. \\n\\nIn prostate cancer studies some of the betulin derivatives displayed dose-dependent anti-invasive activity at nanomolar concentrations with negligible cytotoxicity. The most potent compounds were betulin derivatives with a ring A-fused heterocycle. Also, the carboxyl group at C-28 seemed to be important for activity. These compounds showed considerably improved anti-invasive effects compared to betulinic acid. \\n\\nBetulin derivatives were found to selectively inhibit the ABHD12 serine hydrolase enzyme without inhibiting other endocannabinoid hydrolases and without activity towards cannabinoid receptors. In mechanistic studies, the inhibition type was shown to be reversible. Important structural features required for ABHD12 inhibition were revealed based on our SAR studies. \\n\\nHeterocyclic betulin derivatives were shown to suppress the expression of several inflammation mediators, such as iNOS, IL-6, and MCP-1, a pyrazole derivative being the most potent compound. With further improvement and development, more potent betulin derivatives could be found. \\n\\nThe betulin derivatives show different activity with different targets, which means they are selective. Selectivity and potency could be further improved to obtain a potential betulin-derived compound for further development. In this work, betulin has been shown to be a good starting point for several different drug discovery projects.', 'Mets\u00e4teollisuuden j\u00e4tteen\u00e4 muodostuu joka vuosi tonneittain koivunkuorta, jolle ei toistaiseksi ole taloudellisesti merkitt\u00e4v\u00e4\u00e4 k\u00e4ytt\u00f6\u00e4. T\u00e4ll\u00e4 hetkell\u00e4 sit\u00e4 hy\u00f6dynnet\u00e4\u00e4n k\u00e4yt\u00e4nn\u00f6ss\u00e4 energiaksi polttamalla. Koivun kuoresta saadaan eristetty\u00e4 betuliinia jopa 30 % kuoren kuivapainosta. Betuliini on rakenteeltaan viisirenkainen triterpeeni, jota muodostuu kasvien sekundaarimetaboliittina. Betuliinin johdannaisilla on todettu useita biologisia aktiivisuuksia, mik\u00e4 tekee siit\u00e4 mielenkiintoisen kohteen l\u00e4\u00e4keainetutkimukselle. \\n\\nT\u00e4m\u00e4n v\u00e4it\u00f6skirjaty\u00f6n tarkoituksena oli syntetisoida betuliinista biologisesti aktiivisempia johdannaisia nelj\u00e4\u00e4n eri kohteeseen. Ensimm\u00e4inen kohde oli sis\u00e4elinleishmaniaasia aiheuttava L. donovani -alkuel\u00e4in. L. donovanin aiheuttama leishmaniaasi johtaa hoitamattomana kuolemaan. Olemassa olevat hoidot ovat ongelmallisia huonon hoitomy\u00f6ntyvyyden, alkuel\u00e4inten vastustuskyvyn ja l\u00e4\u00e4kkeiden toksisuuden takia. Toinen kohde oli aggressiivisesti et\u00e4pes\u00e4kkeit\u00e4 muodostava eturauhassy\u00f6p\u00e4. Pitk\u00e4lle edenneeseen eturauhassy\u00f6p\u00e4\u00e4n kuolee edelleen kymmeni\u00e4 tuhansia ihmisi\u00e4 vuosittain. Parantavaa hoitoa et\u00e4pes\u00e4kkeit\u00e4 muodostaneeseen eturauhassy\u00f6p\u00e4\u00e4n ei t\u00e4ll\u00e4 hetkell\u00e4 ole. Kolmas kohde oli hiljattain l\u00f6ydetty (ABHD)12 seriinihydrolaasientsyymi, joka osallistuu endokannabinoidi 2-arakidonoyyliglyserolin (2-AG) metaboliaan. T\u00e4m\u00e4n entsyymin tarkkaa rakennetta tai toimintaa ei tiedet\u00e4, mutta sen on osoitettu vaikuttavan ik\u00e4riippuvaisen hermorappeumah\u00e4iri\u00f6n syntyyn. Nelj\u00e4nten\u00e4 kohteena olivat tulehdusv\u00e4litt\u00e4j\u00e4aineet, kuten COX-2, iNOS, IL-6 ja MCP-1. Tulehdus on elimist\u00f6n normaali reaktio kudosvaurioon tai mikrobeihin, mutta pitkittyess\u00e4\u00e4n ja kroonistuessaan se aiheuttaa kudosvaurioita. Tulehdus on my\u00f6s useiden tautien, kuten reuman, astman tai syd\u00e4n- ja verenkiertoelimist\u00f6n sairauksien taustalla. T\u00e4ll\u00e4 hetkell\u00e4 saatavilla olevat tulehdusl\u00e4\u00e4kkeet eiv\u00e4t aina ole optimaalisia, koska ne eiv\u00e4t tehoa kaikkiin potilaisiin, ne aiheuttavat siet\u00e4m\u00e4tt\u00f6mi\u00e4 sivuvaikutuksia tai ne eiv\u00e4t est\u00e4 taudin etenemist\u00e4. \\n\\nTy\u00f6ss\u00e4 betuliinia muokattiin synteettisesti liitt\u00e4m\u00e4ll\u00e4 fuusioituneita heterosyklej\u00e4 rakenteen A-renkaaseen sek\u00e4 liitt\u00e4m\u00e4ll\u00e4 erilaisia ryhmi\u00e4 C-28-asemaan. Saadut yhdisteet testattiin valittuja biologisia kohteita vastaan ja aktiivisuustulosten perusteella analysoitiin yhdisteiden rakenne-aktiivisuussuhteita. Yhdisteet osoittautuivat selektiivisiksi, sill\u00e4 niiden aktiivisuus vaihteli kohteesta riippuen. Kaikissa tehdyiss\u00e4 biologisissa kokeissa l\u00f6ydettiin aiempaa aktiivisempia betuliinijohdannaisia ja saatiin t\u00e4rke\u00e4\u00e4 tietoa rakenne-aktiivisuussuhteista. Lupaavimmat tulokset saatiin seriinihydrolaasientsyymi- ja eturauhassy\u00f6p\u00e4tutkimuksessa.", "faculty": "farmasia", "charcount": 95671, "commonwords": [["acid", 208], ["derivatives", 182], ["betulin", 147], ["activity", 136], ["compounds", 123], ["figure", 113], ["betulinic", 95], ["showed", 81], ["group", 80], ["\u03bcm", 80], ["ic50", 73], ["cancer", 71], ["ho", 71], ["inhibition", 70], ["against", 64], ["cooh", 62], ["c-28", 61], ["synthesis", 57], ["compound", 56], ["triterpenoids", 49]], "keywords": "", "unit": "farmasian tiedekunta', 'Helsingfors universitet, farmaceutiska fakulteten', 'University of Helsinki, Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology", "status": "doctor", "thesistype": "V\u00e4it\u00f6skirja (artikkeli)', 'Doctoral dissertation (article-based)', 'Doktorsavhandling (sammanl\u00e4ggning)', 'Text", "pagecount": 72, "title": "Synthesis of betulin derivatives with new bioactivities', 'Bioaktiivisten betulinijohdannaisten synteesi", "language": "en", "author": "Haavikko, Raisa", "date": "2015-11-06", "distinctwords": 3654}